Finished
Hemodynamic Monitoring-Guided Goal-Directed Fluid Therapy in Robotic Radical Prostatectomy
NCT07806539 · Antalya Training and Research Hospital · Updated 8 Sept 2026
- What is being tested
- LiDCO-guided goal-directed fluid therapy; Conventional fluid therapy
- For
- Prostate Cancer; Robotic Radical Prostatectomy
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 48 people. The full rules are on the registry page.
- Where
- Turkey (Türkiye)
- When
- Starts or started 23 Feb 2026, ends 15 Aug 2026. Registered 8 Sept 2026.
- Results
- None posted yet.
In the researchers' words
This prospective observational cohort study evaluated goal-directed fluid therapy guided by minimally invasive hemodynamic monitoring in adult male patients undergoing elective robotic radical prostatectomy. Patients were prospectively enrolled and followed according to the intraoperative fluid management strategy used in routine clinical practice. Patients managed with LiDCO®Rapid-guided goal-directed fluid therapy constituted the hemodynamic monitoring-guided group, while patients managed with conventional intraoperative fluid therapy constituted the control group. No randomization or additional research-related intervention was performed. The study compared the two fluid management strategies with respect to intraoperative crystalloid fluid administration and selected perioperative clinical and laboratory parameters.
Sites
- Antalya Training and Research HospitalAntalya, Turkey (Türkiye)
